| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-09 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.25 | 3e-08 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.19 | 1e-05 |